DOXIL for Consolidation Therapy in Ovarian Cancer.

NCT00248248 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Neoplasm

Interventions

DRUG: liposomal doxorubicin

Sponsor

Southeastern Gynecologic Oncology

Collaborators

[object Object]